WINTON GROUP Ltd Buys Shares of 105,583 Siga Technologies Inc. $SIGA

WINTON GROUP Ltd bought a new stake in Siga Technologies Inc. (NASDAQ:SIGA) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 105,583 shares of the company’s stock, valued at approximately $966,000. WINTON GROUP Ltd owned about 0.15% of Siga Technologies at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Jane Street Group LLC lifted its holdings in Siga Technologies by 138.4% in the first quarter. Jane Street Group LLC now owns 114,147 shares of the company’s stock valued at $626,000 after buying an additional 66,265 shares during the period. Strs Ohio acquired a new stake in Siga Technologies during the 1st quarter worth $165,000. Bailard Inc. acquired a new stake in Siga Technologies during the 2nd quarter worth $78,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Siga Technologies during the 2nd quarter valued at $95,000. Finally, American Century Companies Inc. raised its position in shares of Siga Technologies by 2.5% during the 2nd quarter. American Century Companies Inc. now owns 1,405,174 shares of the company’s stock valued at $9,162,000 after acquiring an additional 34,514 shares during the last quarter. Institutional investors and hedge funds own 55.40% of the company’s stock.

Siga Technologies Stock Down 3.6%

NASDAQ SIGA traded down $0.20 during trading on Friday, reaching $5.28. 48,556 shares of the stock traded hands, compared to its average volume of 447,857. Siga Technologies Inc. has a fifty-two week low of $4.95 and a fifty-two week high of $9.62. The firm has a market cap of $377.74 million, a price-to-earnings ratio of 17.08 and a beta of 0.97. The stock’s 50-day moving average price is $6.55 and its 200 day moving average price is $7.20.

Siga Technologies (NASDAQ:SIGA) last posted its earnings results on Tuesday, March 10th. The company reported ($0.08) earnings per share for the quarter. The firm had revenue of $3.79 million during the quarter. Siga Technologies had a return on equity of 11.25% and a net margin of 24.61%. Analysts anticipate that Siga Technologies Inc. will post 1.04 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently issued reports on SIGA. Wall Street Zen lowered Siga Technologies from a “strong-buy” rating to a “hold” rating in a research report on Saturday, November 15th. Weiss Ratings downgraded Siga Technologies from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, January 26th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

About Siga Technologies

Siga Technologies, Inc (NASDAQ: SIGA) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of medical countermeasures for public health emergencies and biological threats. The company’s flagship product, TPOXX® (tecovirimat), is the first and only antiviral approved by the U.S. Food and Drug Administration for the treatment of smallpox. Siga has entered into procurement and development contracts with U.S. government agencies, including the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense, to supply TPOXX® for the Strategic National Stockpile.

Founded in 2002, Siga has built a pipeline of therapies targeting high-consequence pathogens such as smallpox, plague and other potential biothreat agents.